ArticleBMC cancer2026
Factors associated with readmission following reconstruction in head and neck skin cancer: a national readmission database analysis.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundReadmission following reconstructive surgery for head and neck skin cancer is associated with increased morbidity and healthcare costs. However, risk factors in this population are poorly defined. This study aimed to evaluate the incidence, causes, and predictors of 90-day unplanned readmission following reconstructive surgery for head and neck skin cancer.
methodsThis retrospective study included adults with head and neck skin cancer who underwent reconstruction between January and September 2016-2020, extracting data from the National Readmission Database. Patients who died during the index admission or had missing key information were excluded. The primary outcome was 90-day unplanned readmission. Independent predictors were identified using logistic regression analysis. Postoperative acute kidney injury (AKI), identified using International Classification of Disease (ICD) diagnosis codes, was evaluated as a secondary outcome.
resultsIn total, 5,243 patients (mean age 72 years, 78% male) were included, representing 9,490 hospitalizations nationwide. Overall, 1,046 patients (20.0%) experienced 90-day readmission. Private or HMO insurance was associated with lower odds of readmission (aOR = 0.72, 95% CI: 0.57-0.91). Severe liver disease (aOR = 4.69, 95% CI: 1.65-13.33), sepsis (aOR = 1.93, 95% CI: 1.22-3.08), dysphagia (aOR = 1.70, 95% CI: 1.20-2.41), renal disease (aOR = 1.41, 95% CI: 1.17-1.70), and bleeding/hemorrhage (aOR = 1.44, 95% CI: 1.11-1.88) were significant factors associated with readmission. AKI occurred in 306 patients (5.8%).
conclusionsThis study identified severe liver disease, sepsis, dysphagia, and renal disease as factors independently associated with increased 90-day readmission risk. AKI was not uncommon, underscoring the importance of perioperative optimization and vigilant monitoring in high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.